Symbol
RNAC on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
9,555,394 shares
Security Ownership %
37%

Timothy A. Springer ownership in Cartesian Therapeutics, Inc. Common Stock (RNAC)

15 Jan 2025 - Timothy A. Springer has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,555,394 shares of Cartesian Therapeutics, Inc. Common Stock (RNAC). This represents 37% ownership of the company. In their previous filing dated 23 Dec 2024, Timothy A. Springer had reported owning 9,534,216 shares, indicating an increase of +0.22%. .